Firefly Neuroscience, Inc.
AIFF
$1.08
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.00% | 19.19% | 6.03% | -43.97% | 85.82% |
| Total Depreciation and Amortization | 4.44% | 40.63% | -20.00% | -6.98% | 126.32% |
| Total Amortization of Deferred Charges | -- | -- | 11.11% | -- | -- |
| Total Other Non-Cash Items | -6.55% | 87.70% | -62.68% | 123.18% | -96.68% |
| Change in Net Operating Assets | 37.61% | -281.21% | 18.49% | 127.29% | -22.91% |
| Cash from Operations | 10.16% | -7.92% | -21.30% | 37.74% | 4.82% |
| Capital Expenditure | 27.59% | -152.17% | 73.26% | -616.67% | -71.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 27.59% | -152.17% | 73.26% | 96.37% | -33,785.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 230.72% | -- | -- | -- | -88.93% |
| Repurchase of Common Stock | -- | -- | -11,905.26% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 230.72% | 854.40% | 1,415.79% | -101.67% | -88.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,505.00% | 124.08% | 0.94% | 56.08% | -146.89% |